Tenon Medical Inc is a medical device company that has minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.
Last trade$0.00
Day change$0.00 (0.00%)
Day range$1.25 – $1.43
Volume51,752
Market cap$4M
OpenXNAS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$3.6M
Price / earnings
—
Price / book
-2.07×
Price / sales
0.68×
EV / sales
1.18×
EV / EBITDA
-0.5×
Profitability
Earnings per share
-$5.09
Return on assets
-138.05%
Return on equity
785.83%
Dividend yield
0%
Liquidity and leverage
Debt / equity
-2.49×
Current ratio
0.58×
Quick ratio
0.48×
Cash ratio
0.2×
Cash flow
Price / cash flow
—
Price / free cash flow
—
Free cash flow
-$12.83M
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for TNON, quarterly periods
Line item
Q2 FY2026 Jun 30, 2026
Q1 FY2026 Mar 31, 2026
Q4 FY2025 Dec 31, 2025
Q3 FY2025 Sep 30, 2025
Q2 FY2025 Jun 30, 2025
Q1 FY2025 Mar 31, 2025
Q4 FY2024 Dec 31, 2024
Q3 FY2024 Sep 30, 2024
Revenue
$1.28M
$1.38M
$1.48M
$1.17M
$564K
$726K
$770K
$887K
Cost of revenue
$465K
$434K
$464K
$400K
$319K
$403K
$417K
$469K
Gross profit
$814K
$945K
$1.02M
$773K
$245K
$323K
$353K
$418K
Selling, general and administrative
$3.4M
$3.56M
$3.36M
$3.74M
$2.6M
$3.31M
$2.96M
$2.98M
Research and development
$768K
$662K
$527K
$428K
$503K
$691K
$569K
$657K
Total operating expenses
$4.17M
$4.23M
$3.88M
$4.17M
$3.1M
$4M
$3.53M
$3.63M
Operating income
-$3.35M
-$3.28M
-$2.87M
-$3.39M
-$2.86M
-$3.68M
-$3.17M
-$3.22M
Interest expense
-$852K
-$176K
$0
$0
$0
$0
$0
$0
Income before taxes
-$4.05M
-$3.48M
-$2.83M
-$3.34M
-$2.77M
-$3.62M
-$3.09M
-$3.18M
Income taxes
$0
$0
$0
$0
$0
$0
$0
$0
Net income
-$4.05M
-$3.48M
-$2.83M
-$3.34M
-$2.77M
-$3.62M
-$3.09M
-$3.18M
Net income attributable to common shareholders
-$4.05M
-$3.48M
-$2.83M
-$3.34M
-$2.77M
-$3.62M
-$3.09M
-$3.18M
EBITDA
-$3.29M
-$3.19M
-$2.77M
-$3.32M
-$2.81M
-$3.64M
-$3.06M
-$3.11M
Basic earnings per share
-$12.35
-$10.85
-$9.82
-$14.00
-$12.76
-$35.35
-$34.27
-$127.05
Diluted earnings per share
-$12.35
-$10.85
-$9.82
-$14.00
-$12.76
-$35.35
-$34.27
-$127.05
Recent news
Company coverage with links to the original publishers.
Tenon Medical reported Q4 2025 revenue of $1.5 million, up 92% year-over-year, with full-year revenue of $3.9 million representing 20% growth. The company achieved record gross margins of 69% in Q4 (up from 46%) driven by operational efficiencies. Key milestones include FDA 510(k) clearance for the SImmetry+ SI-Joint Fusion System and successful initial clinical cases. The company closed a $4.3 million senior convertible note financing post-quarter end and ended the period with $3.8 million in cash and zero debt. Management highlighted strong physician adoption momentum and multiple product launches planned for 2026.
Shares of SurgePays, Inc. (NASDAQ: SURG) fell sharply in today’s pre-market trading after the company reported worse-than-expected fourth-quarter financial results.
Surgepays posted GAAP earnings of 19 cents per share, missing market estimates of 41 cents per share. The company’s quarterly sales came in at $32.318 million versus expectations of $33.521 million, according to data from Benzinga Pro.
SurgePays shares dipped 14.6% to $5.97 in pre-market trading
Here are some other stocks moving in pre-market trading.
Gainers
NuCana plc (NASDAQ: NCNA) gained 99.6% to $0.7806 in pre-market trading after the company was granted U.S. Patent #11925658 for "Phosphoramidate Derivatives For Use In The Treatment Of Cancer; Especially In The Treatment Where The Patient Shows Resistance"
ShiftPixy, Inc. (NASDAQ: PIXY) shares rose 50% to $4.71 in pre-market trading after dipping over 19% on Tuesday.
Tenon Medical, Inc. (NASDAQ: TNON) rose 48.2% to $2.15 in pre-market trading after the company reported better-than-expected fourth-quarter GAAP EPS results.
Minim, Inc. (NASDAQ: MINM) gained 39.8% to ...
Edible Garden AG Incorporated (NASDAQ: EDBL) shares fell on Monday following third-quarter results.
Edible Garden posted a quarterly loss of 69 cents per share, compared to a year-ago loss of $7.20 per share, according to Benzinga Pro. The company’s quarterly sales came in at $3.29 million.
Edible Garden shares fell on Monday fell 17.6% to $0.5315 during Monday’s session.
Gainers
Tenax Therapeutics, Inc (NASDAQ: TENX) shares jumped 130% to $0.3588 after the company announced FDA clearance of IND for TNX-103 for the treatment of pulmonary hypertension with heart failure with preserved ejection fraction.
Tivic Health Systems, Inc. (NASDAQ: TIVC) gained 81.3% to $2.1750. BestGrowthStocks.Com issued comprehensive analysis of Tivic Health Systems.
MSP Recovery, Inc. (NASDAQ: LIFW) jumped 40.6% to $7.47.
ZyVersa Therapeutics, Inc. (NASDAQ: ZVSA) shares climbed 35.8% to $0.09.
Xos, Inc. (NASDAQ: XOS) gained 26% to $0.42.
Collective Audience, Inc. (NASDAQ: CAUD) shares climbed 23.9% to $3.6801 after jumping around 30% on Friday.
Montauk Renewables, Inc. (NASDAQ: MNTK) gained 23% to $7.91. Scotiabank upgraded Montauk Renewables from Sector Perform to Sector Outperform and announced a $9 price target.
Near Intelligence, Inc. (NASDAQ: NIR) shares climbed 21% to $0.23 after dipping 31% on Friday.
Cingulate Inc. (NASDAQ: CING) gained 20.5% to $0.3798.
INVO Bioscience, Inc. (NASDAQ: INVO) rose 18% to $1.5400.
Cyngn Inc. (NASDAQ: CYN) climbed 18% to $0.2011.
TETRA Technologies, Inc. (NYSE: TTI) gained 16.6% to $5.01. Exxon Mobil Corp is reportedly planning to unveil its long-awaited lithium strategy today. The company aims to produce at least 10,000 metric ...
Gainers
Senti Biosciences, Inc. (NASDAQ: SNTI) shares surged 120.8% to $0.6450 in pre-market trading after the company reported a new strategic collaboration with Celest Therapeutics for the clinical development of SENTI-301A in China.
Tharimmune, Inc. (NASDAQ: THAR) shares rose 76.8% to $0.2790 in pre-market trading as the company disclosed the execution of an exclusive worldwide licensing agreement with Avior Inc. d/b/a Avior Bio, LLC to develop, market and commercialize a clinical-stage asset, AV104.
TransMedics Group, Inc. (NASDAQ: TMDX) shares rose 39.7% to $56.16 in pre-market trading after the company reported better-than-expected third-quarter sales results and issued strong FY23 revenue guidance.
GSE Systems, Inc. (NASDAQ: GVP) rose 18.3% to $3.88 in pre-market trading. GSE Solutions was recently awarded a $4.2 million contract from a large utility for nuclear power plant engineering work.
Unisys Corporation (NYSE: UIS) shares climbed 17.7% to $3.40 in pre-market trading after the company posted upbeat third-quarter results ...
Gainers
Benson Hill, Inc. (NYSE: BHIL) shares jumped 48.1% to $0.3740.
Seres Therapeutics, Inc. (NASDAQ: MCRB) climbed 45.9% to $1.20. Seres Therapeutics, on Thursday, posted a narrower-than-expected quarterly loss.
Qurate Retail, Inc. (NASDAQ: QRTEA) surged 44% to $0.6181 following third-quarter results.
Cooper-Standard Holdings Inc. (NYSE: CPS) shares climbed 41% to $17.94 following better-than-expected third-quarter results.
Tenon Medical, Inc. (NASDAQ: TNON) shares climbed 39.6% to $1.20 after the company announced it passed an FDA Level 2 Inspection.
Udemy, Inc. (NASDAQ: UDMY) surged 38.1% to $12.46 following strong quarterly earnings.
Vivakor, Inc. (NASDAQ: VIVK) climbed 32.7% to $0.77.
Alpha Technology Group Limited (NASDAQ: ATGL) gained 32.5% to $6.64. Alpha Technology Group recently announced the closing of its initial public offering of 1,750,000 ordinary shares at a public offering price of $4.00 per share.
Werewolf Therapeutics, Inc. (NASDAQ: HOWL) rose 29.8% to $2.7888. Werewolf Therapeutics released preliminary results from initial monotherapy dose-escalation cohorts of an ongoing Phase 1/1b trial of WTX-124 in patients with advanced or metastatic solid tumors.
Enlivex Therapeutics Ltd. (NASDAQ: ENLV) jumped 28.5% to $1.8250.
Syra Health Corp. (NASDAQ: SYRA) gained 27.8% to $1.5981.
Dermata Therapeutics, Inc. (NASDAQ: DRMA) rose 26% to $0.76.
Redfin Corporation (NASDAQ: RDFN) climbed 25.2% to $6.35 following third-quarter results.
Phoenix Motor Inc. (NASDAQ: PEV) gained 25% to $0.93.
DarioHealth Corp. (NASDAQ: DRIO) gained 24.7% to $1.2601.
CVRx, Inc. (NASDAQ: CVRX) climbed 24.7% to $16.99. CVRx said Centers for Medicare and Medicaid Services has reassigned the Barostim implant procedure for procedures performed in the outpatient setting as part of the 2024 Medicare Hospital Outpatient Prospective Payment System final rule.
Net Lease Office Properties (NYSE: NLOP) gained 24% to $12.98.
Proto Labs, Inc. (NYSE: PRLB) climbed 23.1% to $29.93. Proto Labs reported third-quarter FY2 revenue growth of 7.4% ...
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
No prior dividend records found.
Stock splits
Historical share-structure events and their execution dates.